From: Erythropoietin in Acute Kidney Injury (EAKI): a pragmatic randomized clinical trial
Group without EPO | Group with EPO | |||||
---|---|---|---|---|---|---|
OR | 95%CI | p | OR | 95%CI | p | |
Age | 1.04 | 0.99,1.09 | 0.139 | 1.02 | 0.98,1.06 | 0.426 |
Gender Ref: Male | 1.72 | 0.49,5.94 | 0.389 | 0.45 | 0.14,1.46 | 0.184 |
Smoking | 0.40 | 0.09,1.62 | 0.199 | 2.18 | 0.61,7.76 | 0.228 |
Diabetes | 0.79 | 0.24,2.68 | 0.713 | 0.78 | 0.24,2.50 | 0.673 |
Hypertension | 4.73 | 0.59,37.28 | 0.140 | 5.93 | 1.16,30.42 | 0.033 |
Previous CVD | 0.41 | 0.11,1.50 | 0.180 | 0.98 | 0.31,3.18 | 0.979 |
COPD | 1.13 | 0.21,5.97 | 0.890 | 1.22 | 0.34,4.43 | 0.760 |
Baseline eGFR | 1.00 | 0.98,1.03 | 0.821 | 0.99 | 0.97,1.01 | 0.464 |
Hemoglobin T1 | 1.19 | 0.75,1.89 | 0.470 | 1.56 | 0.91,2.68 | 0.109 |
AKI stage 2 or 3 Ref: AKI stage 1 | 1.72 | 0.49,5.94 | 0.389 | 0.45 | 0.14,1.46 | 0.184 |
Serum creatinine T1 | 0.96 | 0.79,1.15 | 0.641 | 0.94 | 0.77,1.16 | 0.579 |
Oligoanuria | 0.34 | 0.08,1.39 | 0.131 | 0.06 | 0.01,0.23 | < 0.001 |
CRP T1 | 1.01 | 1.001,1.02 | 0.039 | 1.01 | 0.99,1.02 | 0.134 |
Serum phosphate | 0.79 | 0.59,1.06 | 0.120 | 0.78 | 0.62,0.99 | 0.044 |
Ferritin | 1.00 | 0.99,1.002 | 0.775 | 0.99 | 0.99,1.003 | 0.666 |
Hemoglobin T2 | 0.99 | 0.61,1.59 | 0.965 | 2.48 | 1.24,4.96 | 0.010 |
CRP T2 | 0.99 | 0.98,1.008 | 0.701 | 0.99 | 0.98,1.008 | 0.505 |
Iron intake | 1.28 | 0.24,6.70 | 0.771 | 3.87 | 0.78,19.15 | 0.097 |
Corticosteroid use | 1.71 | 0.42,7.02 | 0.454 | 0.46 | 0.14,1.52 | 0.202 |
Vasopressor use | 0.22 | 0.03,1.77 | 0.156 | 0.28 | 0.08,1.003 | 0.051 |